| Human Albumin CSL Behring, 200 g/l, solution for infusion PA0800/012/001 |
Human albumin solution |
CSL Behring GmbH |
Not marketed |
| Humira 20 mg solution for injection in pre-filled syringe EU/1/03/256/022 |
Adalimumab |
AbbVie Deutschland GmbH & Co. KG |
— |
| Humira 40 mg/0.8 ml solution for injection EU/1/03/256/1-10 |
Adalimumab |
AbbVie Deutschland GmbH & Co. KG |
— |
| Humira 80 mg solution for injection in pre-filled syringe EU/1/03/256/020 |
Adalimumab |
AbbVie Deutschland GmbH & Co. KG |
— |
| Humulin I (Isophane) 100 IU/ml Suspension for Injection in cartridge PA2276/002/004 |
Human insulin (recombinant dna origin) |
Eli Lilly Nederland B.V. |
Marketed |
| Humulin I (Isophane) 100 IU/ml Suspension for Injection in vial PA2276/002/003 |
Human insulin (recombinant dna origin) |
Eli Lilly Nederland B.V. |
Not marketed |
| Humulin I KwikPen (Isophane) 100 IU/ml Suspension for Injection PA2276/005/002 |
Human insulin (recombinant dna origin) |
Eli Lilly Nederland B.V. |
Marketed |
| Humulin M3 (Mixture 3) 100 IU/ml Suspension for Injection in cartridge PA2276/003/004 |
Human insulin (recombinant dna origin) |
Eli Lilly Nederland B.V. |
Marketed |
| Humulin M3 (Mixture 3) 100 IU/ml Suspension for Injection in vial PA2276/003/003 |
Human insulin (recombinant dna origin) |
Eli Lilly Nederland B.V. |
Not marketed |
| Humulin M3 KwikPen (mixture 3) 100 IU/ml Suspension for Injection PA2276/006/002 |
Human insulin (recombinant dna origin) |
Eli Lilly Nederland B.V. |
Marketed |
| Humulin M3 KwikPen (mixture 3) 100 IU/ml Suspension for Injection PPA0465/501/001 |
Human insulin (recombinant dna origin) |
PCO Manufacturing Ltd. |
— |
| Humulin S (Soluble) 100 IU/ml Solution for Injection in vial PA2276/001/003 |
Human insulin (recombinant dna origin) |
Eli Lilly Nederland B.V. |
Not marketed |
| Humulin S (Soluble), 100 IU/ml Solution for Injection in cartridge PA2276/001/004 |
Human insulin (recombinant dna origin) |
Eli Lilly Nederland B.V. |
Marketed |
| Hyaluronidase 1500 I.U. Powder for Solution for Injection or Infusion PA0281/231/001 |
Hyaluronidase |
Pinewood Laboratories Ltd |
Marketed |
| HYCAMTIN 0.25 mg hard capsules EU/1/96/027/006 |
Topotecan hydrochloride |
Sandoz Pharmaceuticals d.d. |
— |
| HYCAMTIN 1 mg hard capsules EU/1/96/027/007 |
Topotecan hydrochloride |
Sandoz Pharmaceuticals d.d. |
— |
| Hycamtin 1 mg powder for concentrate for solution for infusion EU/1/96/027/004 |
Topotecan (as hydrochloride) |
Sandoz Pharmaceuticals d.d. |
— |
| HYCAMTIN 1 mg powder for concentrate for solution for infusion EU/1/96/027/005 |
Topotecan (as hydrochloride) |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Hycamtin 4 mg powder for concentrate for solution for infusion EU/1/96/027/003 |
Topotecan hydrochloride |
Sandoz Pharmaceuticals d.d. |
— |
| HYCAMTIN 4 mg powder for concentrate for solution for infusion EU/1/96/027/001 |
Topotecan hydrochloride |
Sandoz Pharmaceuticals d.d. |
— |
| Hydrea 500 mg Hard Capsules PA2239/021/001 |
Hydroxycarbamide |
CHEPLAPHARM Arzneimittel GmbH |
Marketed |
| Hydrex Surgical Scrub 4.0% w/v Cutaneous Solution PA1843/001/001 |
Chlorhexidine gluconate |
Ecolab Deutschland GmbH |
Marketed |
| Hydrocortisone 1% w/w Cream PA0206/030/001 |
Hydrocortisone |
Ovelle Limited |
Marketed |
| Hydrocortisone 10 mg Tablets PA22865/003/001 |
Hydrocortisone |
Renata Pharmaceuticals (Ireland) Limited |
Marketed |
| Hydrocortisone 20 mg Tablets PA22865/003/002 |
Hydrocortisone |
Renata Pharmaceuticals (Ireland) Limited |
Not marketed |
| Hydrocortisone 5 mg Tablets PA22865/003/003 |
Hydrocortisone |
Renata Pharmaceuticals (Ireland) Limited |
Marketed |
| Hydrocortisone Hualan 10 mg tablets PA23341/001/003 |
Hydrocortisone |
Hualan Pharmaceuticals Limited |
Not marketed |
| Hydrocortisone Hualan 15 mg tablets PA23341/001/004 |
Hydrocortisone |
Hualan Pharmaceuticals Limited |
Not marketed |
| Hydrocortisone Hualan 2.5 mg tablets PA23341/001/001 |
Hydrocortisone |
Hualan Pharmaceuticals Limited |
Not marketed |
| Hydrocortisone Hualan 20 mg tablets PA23341/001/005 |
Hydrocortisone |
Hualan Pharmaceuticals Limited |
Not marketed |
| Hydrocortisone Hualan 5 mg tablets PA23341/001/002 |
Hydrocortisone |
Hualan Pharmaceuticals Limited |
Not marketed |
| Hydrocortone 10 mg Tablets PA1986/054/001 |
Hydrocortisone |
Teva B.V. |
Marketed |
| Hydromorphone Hydrochloride 20 mg/ml Solution for Injection/Concentrate for Solution for Infusion PA0549/030/001 |
Hydromorphone hydrochloride |
Ethypharm |
Not marketed |
| Hydromorphone hydrochloride 20 mg/ml solution for injection/infusion PA2165/023/001 |
Hydromorphone hydrochloride |
AS Kalceks |
Marketed |
| Hydromorphone Hydrochloride 50 mg/ml Solution for Injection/Concentrate for Solution for Infusion PA0549/030/002 |
Hydromorphone hydrochloride |
Ethypharm |
Not marketed |
| Hydromorphone hydrochloride 50 mg/ml solution for injection/infusion PA2165/023/002 |
Hydromorphone hydrochloride |
AS Kalceks |
— |
| Hydroxocobalamin 1 mg/ml solution for injection PA1770/002/001 |
Hydroxocobalamin acetate |
G.L. Pharma GmbH |
Marketed |
| Hydroxy-Vit 1000 microgram/ml solution for injection PA1113/031/001 |
Hydroxocobalamin chloride |
Phoenix Labs Unlimited Company |
Not marketed |
| Hydroxyzine hydrochloride 25 mg film-coated tablets PA22749/025/001 |
Hydroxyzine hydrochloride |
Brillpharma (Ireland) Limited |
Not marketed |
| HYFTOR 2 mg/g Gel EU/1/23/1723/001 |
Sirolimus |
Plusultra Pharma GmbH |
— |
| Hympavzi 150 mg solution for injection in pre-filled pen EU/1/24/1874/002 |
Marstacimab |
Pfizer Europe MA EEIG |
— |
| Hympavzi 150 mg solution for injection in pre-filled syringe EU/1/24/1874/001 |
Marstacimab |
Pfizer Europe MA EEIG |
— |
| Hyoscine Hydrobromide Martindale Pharma 600 micrograms/ml Solution for Injection PA0549/031/002 |
Hyoscine hydrobromide |
Ethypharm |
Marketed |
| Hypericum HOR1149/015/001 |
Hypericum perforatum |
A. Nelson & Company Limited |
Not marketed |
| Hypnovel 10 mg/2 ml Solution for Injection PA2239/007/001 |
Midazolam hydrochloride |
CHEPLAPHARM Arzneimittel GmbH |
Marketed |
| Hypnovel 10 mg/5 ml Solution for Injection PA2239/007/002 |
Midazolam hydrochloride |
CHEPLAPHARM Arzneimittel GmbH |
Marketed |
| Hypovase 0.5mg Tablets PA0822/195/001 |
Prazosin |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| HyQvia 100 mg/mL solution for infusion for subcutaneous use EU/1/13/840/001-006 |
Human normal immunoglobulin |
Baxalta Innovations GmbH |
— |
| Hyrimoz 20 mg solution for injection in pre-filled syringe EU/1/18/1286/007 |
Adalimumab |
Sandoz GmbH |
— |
| Hyrimoz 40 mg solution for injection in pre-filled pen EU/1/18/1286/004-006 |
Adalimumab |
Sandoz GmbH |
— |